Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNH-119014 in healthy volunteers
NCT07087262Phase 1Recruiting
- Sponsor
- ScinnoHub Pharmaceutical
- Start
- Jun 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Hemolytic anemia (HA) comparing SNH-119014 with Placebo (2 arms). Primary endpoints: Number of Participants With Adverse Events/Serious Adverse Events That Are Related to Treatment, Number of Participants With Abnormal Laboratory Values and 2 more. Started Jun 2025; status: recruiting.
02
Drugs
SNH-119014
03
Conditions
Hemolytic anemia (HA)
Beyond the preview
Go deeper on NCT07087262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07087262.